149 related articles for article (PubMed ID: 21879295)
1. Animal tumor models for PET in drug development.
Toyohara J; Ishiwata K
Ann Nucl Med; 2011 Dec; 25(10):717-31. PubMed ID: 21879295
[TBL] [Abstract][Full Text] [Related]
2. Positron emitting tracers in pre-clinical drug development.
Fernandes E; Barbosa Z; Clemente G; Alves F; Abrunhosa AJ
Curr Radiopharm; 2012 Apr; 5(2):90-8. PubMed ID: 22280107
[TBL] [Abstract][Full Text] [Related]
3. PET tracer development--a tale of mice and men.
Hicks RJ; Dorow D; Roselt P
Cancer Imaging; 2006 Oct; 6(Spec No A):S102-6. PubMed ID: 17114061
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography in CNS drug discovery and drug monitoring.
Piel M; Vernaleken I; Rösch F
J Med Chem; 2014 Nov; 57(22):9232-58. PubMed ID: 25144329
[TBL] [Abstract][Full Text] [Related]
5. [Application of pre-clinical PET imaging for drug development].
Tsukada H
Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Nov; 31(5-6):231-7. PubMed ID: 22256612
[TBL] [Abstract][Full Text] [Related]
6. Positron emission tomographic imaging in drug discovery.
Ghosh KK; Padmanabhan P; Yang CT; Ng DCE; Palanivel M; Mishra S; Halldin C; Gulyás B
Drug Discov Today; 2022 Jan; 27(1):280-291. PubMed ID: 34332093
[TBL] [Abstract][Full Text] [Related]
7. In vivo PET/CT in a human glioblastoma chicken chorioallantoic membrane model: a new tool for oncology and radiotracer development.
Warnock G; Turtoi A; Blomme A; Bretin F; Bahri MA; Lemaire C; Libert LC; Seret AE; Luxen A; Castronovo V; Plenevaux AR
J Nucl Med; 2013 Oct; 54(10):1782-8. PubMed ID: 23970367
[TBL] [Abstract][Full Text] [Related]
8. [¹¹C]Sorafenib: radiosynthesis and preclinical evaluation in tumor-bearing mice of a new TKI-PET tracer.
Poot AJ; van der Wildt B; Stigter-van Walsum M; Rongen M; Schuit RC; Hendrikse NH; Eriksson J; van Dongen GA; Windhorst AD
Nucl Med Biol; 2013 May; 40(4):488-97. PubMed ID: 23522977
[TBL] [Abstract][Full Text] [Related]
9. Translational PET imaging research.
Hargreaves RJ; Rabiner EA
Neurobiol Dis; 2014 Jan; 61():32-8. PubMed ID: 24055214
[TBL] [Abstract][Full Text] [Related]
10. Bridging the gaps in
Campbell MG; Mercier J; Genicot C; Gouverneur V; Hooker JM; Ritter T
Nat Chem; 2016 Dec; 9(1):1-3. PubMed ID: 27995923
[No Abstract] [Full Text] [Related]
11. Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery.
Ruggeri BA; Camp F; Miknyoczki S
Biochem Pharmacol; 2014 Jan; 87(1):150-61. PubMed ID: 23817077
[TBL] [Abstract][Full Text] [Related]
12. High tumor uptake of (64)Cu: implications for molecular imaging of tumor characteristics with copper-based PET tracers.
Jørgensen JT; Persson M; Madsen J; Kjær A
Nucl Med Biol; 2013 Apr; 40(3):345-50. PubMed ID: 23394821
[TBL] [Abstract][Full Text] [Related]
13. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
Vallabhajosula S
Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
[TBL] [Abstract][Full Text] [Related]
14. Small animal PET in oncology: the road from bench to bedside.
Ambrosini V; Quarta C; Nanni C; Pettinato C; Franchi R; Grassetto G; Al-Nahhas A; Fanti S; Rubello D
Cancer Biother Radiopharm; 2009 Apr; 24(2):277-85. PubMed ID: 19409051
[TBL] [Abstract][Full Text] [Related]
15. The role of molecular imaging in modern drug development.
Cunha L; Szigeti K; Mathé D; Metello LF
Drug Discov Today; 2014 Jul; 19(7):936-48. PubMed ID: 24434047
[TBL] [Abstract][Full Text] [Related]
16. Antibody positron emission tomography imaging in anticancer drug development.
Lamberts LE; Williams SP; Terwisscha van Scheltinga AG; Lub-de Hooge MN; Schröder CP; Gietema JA; Brouwers AH; de Vries EG
J Clin Oncol; 2015 May; 33(13):1491-504. PubMed ID: 25779566
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Hsp90 inhibitor NVP-AUY922 in multicellular tumour spheroids with respect to effects on growth and PET tracer uptake.
Monazzam A; Razifar P; Ide S; Rugaard Jensen M; Josephsson R; Blomqvist C; Langström B; Bergström M
Nucl Med Biol; 2009 Apr; 36(3):335-42. PubMed ID: 19324279
[TBL] [Abstract][Full Text] [Related]
18. PET of signal transduction pathways in cancer.
Holland JP; Cumming P; Vasdev N
J Nucl Med; 2012 Sep; 53(9):1333-6. PubMed ID: 22879078
[TBL] [Abstract][Full Text] [Related]
19. Preclinical Testing of Radiopharmaceuticals for the Detection and Characterization of Osteomyelitis: Experiences from a Porcine Model.
Alstrup AKO; Jensen SB; Nielsen OL; Jødal L; Afzelius P
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299496
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of O-[(18)F]fluoromethyl-D-tyrosine as a radiotracer for tumor imaging with positron emission tomography.
Urakami T; Sakai K; Asai T; Fukumoto D; Tsukada H; Oku N
Nucl Med Biol; 2009 Apr; 36(3):295-303. PubMed ID: 19324275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
